v3.24.2.u1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 31,314 $ 25,841
Short-term investments 3,978 25,884
Restricted cash 146 146
Accounts receivable 2,422 34,108
Inventories 18,749 9,706
Other current assets 5,801 6,184
Total current assets 62,410 101,869
Property and equipment, net 2,317 3,856
Operating lease assets 48,948 54,935
Other assets 3,609 4,844
Total assets 117,284 165,504
Current liabilities:    
Accounts payable 5,253 3,684
Accrued compensation 7,269 11,519
Accrued research and development expenses 2,014 17,364
Deferred revenue 107,582 77,833
Other current liabilities 26,149 31,826
Total current liabilities 148,267 142,226
Deferred revenue - long-term 567 37,562
Operating lease liabilities - long-term 38,703 45,693
Liability related to the sale of future revenues - long-term 36,448 34,623
Other long-term liabilities 4,167 4,631
Total liabilities 228,152 264,735
Commitments and contingencies (Note 8)
Stockholders' equity (deficit):    
Common stock - $0.0001 par value, 500,000 shares authorized as of June 30, 2024 and December 31, 2023; 4,904 and 4,258 shares issued and utstanding as of June 30, 2024 and December 31, 2023, respectively 0 0
Additional paid-in capital 1,909,097 1,870,123
Accumulated other comprehensive (loss) income (14) (204)
Accumulated deficit (2,019,951) (1,969,150)
Total stockholders' equity (deficit) (110,868) (99,231)
Total liabilities and stockholders' equity (deficit) $ 117,284 $ 165,504

Source

10-Q
HTML PDF
XBRL
ZIP